中性粒子のエラスタゼは,がん細胞を選択的に殺し,腫瘍発生を弱める

Chang Cui¹, Kasturi Chakraborty², Xu Anna Tang²

¹Committee on Cancer Biology, The University of Chicago, Chicago, IL 60637, USA; Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.

Cell

|May 8, 2021

まとめ

中性粒子の弾性酶 (ELANE) は,CD95死亡領域を標的として,多様な癌細胞を選択的に殺し,最小限の宿主毒性で潜在的な広範な抗癌療法を提供します. この先天的な免疫酵素は癌の治療に有望です

科学分野:

免疫学
腫瘍学
生物化学

背景:

癌の遺伝的多様性と宿主細胞の類似性は幅広い治療開発に挑戦しています
がん細胞を選択的に標的とする生まれつきの免疫系の能力はほとんど未知のものです

研究の目的:

広範な抗がん療法として,先天性免疫,特に中性粒子の弾性酵素 (ELANE) の可能性を調査する.
ELANEが選択的に癌細胞を排除するメカニズムを解明する.

主な方法:

ヒトとマウスの中性粒子の機能の分析
様々な癌細胞に対する中性粒子の弾性酵素 (ELANE) の活性に関する調査.
ELANEの作用メカニズムは,CD95死亡領域とヒストンH1イソフォームを含む.
ELANEの原発性腫瘍増殖とアブスコパルの効果の評価
豚の臓エラスタゼを治療の代替として評価する.

主要な成果:

ヒト中性粒子は活性ELANEを放出し,様々な癌細胞を選択的に殺し,非癌細胞は保存する.
ELANEはCD95死亡ドメインを解放し,がん細胞の根絶のためにヒストンH1同型と相互作用します.
ELANE治療は原発性腫瘍の増殖を抑制し,遠隔転移に対するCD8+ T細胞媒介のアブスコパルの効果を誘導した.
豚の臓のエラスタゼは,腫瘍由来プロテアゼ阻害剤に対する治療効果と耐性を高めました.

結論:

ELANEは,遺伝的に多様ながん細胞に対して選択的細胞毒性を示し,宿主に対する毒性は最小限である.
ELANEのメカニズムは幅広いがんの治療に新しい治療戦略を提供します
ELANEとその類似品は,新しい抗がん療法の開発に有望な候補です.

キーワード:

CD95 について癌についてヒストンH1 中性粒子の状態中性粒子治療薬腫瘍免疫学

さらに関連する動画

10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.2K

14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.6K

関連する概念動画

02:57

Targeted Cancer Therapies

8.0K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

8.0K

02:38

Mitogens and the Cell Cycle

7.2K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

7.2K

02:53

Adaptive Mechanisms in Cancer Cells

6.1K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

6.1K

02:15

Replicative Cell Senescence

4.0K

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...

4.0K

01:28

Cells of the Innate Immune Response

7.4K

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

7.4K

02:40

Cancer Stem Cells and Tumor Maintenance

5.2K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...